Consult a healthcare provider for medical advice on the best treatment for your underlying condition
Semaglutide commonly causes mild nausea, early satiety, or stomach upset during dose escalation
The advantages of GLP-1 agonists include substantial clinical trial data supporting their efficacy and safety, FDA approval for weight management in certain populations, proven results with many users losing 15-20% or more of body weight, and effects on appetite that make caloric restriction feel natural
Wearden AJ, Morriss RK, Mullis R, et al
[Accessed 9 th September 2025] MOUNJARO- tirzepatide injection, solution
How long does reconstituted Melanotan 2 last in the fridge